Upexi, Inc. (NASDAQ:UPXI - Get Free Report) CEO Allan Marshall bought 161,943 shares of the firm's stock in a transaction that occurred on Friday, July 11th. The stock was purchased at an average cost of $4.94 per share, for a total transaction of $799,998.42. Following the completion of the purchase, the chief executive officer owned 1,046,261 shares of the company's stock, valued at $5,168,529.34. This trade represents a 18.31% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Upexi Stock Performance
Shares of UPXI stock traded down $0.23 during trading hours on Monday, reaching $5.88. 8,314,196 shares of the company's stock were exchanged, compared to its average volume of 12,209,046. Upexi, Inc. has a fifty-two week low of $1.90 and a fifty-two week high of $22.57. The stock's 50 day moving average is $7.96 and its 200-day moving average is $5.96. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.24 and a current ratio of 0.37.
Upexi (NASDAQ:UPXI - Get Free Report) last released its quarterly earnings data on Friday, May 16th. The company reported ($2.87) EPS for the quarter. Upexi had a negative net margin of 135.86% and a negative return on equity of 535.19%. The business had revenue of $3.16 million during the quarter.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Upexi to a "hold" rating in a research report on Friday, May 30th. Cantor Fitzgerald raised shares of Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 price objective for the company in a research note on Monday, June 16th.
Check Out Our Latest Analysis on UPXI
Hedge Funds Weigh In On Upexi
A number of institutional investors have recently added to or reduced their stakes in the stock. Bank of Montreal Can purchased a new stake in shares of Upexi in the 4th quarter valued at $36,000. North Star Investment Management Corp. acquired a new position in Upexi in the 2nd quarter valued at about $45,000. Finally, Kathmere Capital Management LLC purchased a new stake in Upexi during the second quarter worth about $6,535,000. Hedge funds and other institutional investors own 5.68% of the company's stock.
About Upexi
(
Get Free Report)
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Recommended Stories
Before you consider Upexi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upexi wasn't on the list.
While Upexi currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access